Abstract:Melanoma is the most malignant skin cancer, which originates from epidermal melanocytes, with increasing worldwide incidence. The escape of immune surveillance is a hallmark of the tumor, which is manifested by the imbalance between the enhanced immune evasion of tumor cells and the impaired antitumor capacity of infiltrating immune cells. According to this notion, the invigoration of the exhausted immune cells by immune checkpoint blockades has gained encouraging outcomes in eliminating tumor cells and significantly prolonged the survival of patients, particularly in melanoma. Epigenetics is a pivotal non-genomic modulatory paradigm referring to heritable changes in gene expression without altering genome sequence, including DNA methylation, histone modification, non-coding RNAs, and m6A RNA methylation. Accumulating evidence has demonstrated how the dysregulation of epigenetics regulates multiple biological behaviors of tumor cells and contributes to carcinogenesis and tumor progression in melanoma. Nevertheless, the linkage between epigenetics and antitumor immunity, as well as its implication in melanoma immunotherapy, remains elusive. In this review, we first introduce the epidemiology, clinical characteristics, and therapeutic innovations of melanoma. Then, the tumor microenvironment and the functions of different types of infiltrating immune cells are discussed, with an emphasis on their involvement in antitumor immunity in melanoma. Subsequently, we systemically summarize the linkage between epigenetics and antitumor immunity in melanoma, from the perspective of distinct paradigms of epigenetics. Ultimately, the progression of the clinical trials regarding epigenetics-based melanoma immunotherapy is introduced.

Genetics and epigenetics of melanoma

Epigenetics Regulates Antitumor Immunity in Melanoma

Linking Cellular Metabolism to Epigenetics in Melanoma

Exploring the Complex and Multifaceted Interplay between Melanoma Cells and the Tumor Microenvironment

Non-Surgical Treatment Methodologies and Prevention for Malignant Melanoma

Role of Epigenetics in Uveal Melanoma

Dangerous liaisons: Loss of keratinocyte control over melanocytes in melanomagenesis

Current understanding of epigenetics role in melanoma treatment and resistance

Signal pathways of melanoma and targeted therapy

Aetiology and Pathogenesis of Cutaneous Melanoma: Current Concepts and Advances

Pathogenesis, Diagnosis, and Therapeutic Advances

Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises

Cell Senescence and the Genetics of Melanoma Development

Epigenetics and cutaneous neoplasms: from mechanism to therapy

Mucosal Melanoma: Pathological Evolution, Pathway Dependency and Targeted Therapy

The Cross Talk between Cellular Senescence and Melanoma: From Molecular Pathogenesis to Target Therapies

Melanogenesis and the Targeted Therapy of Melanoma

Advances in Understanding Drug Resistance Mechanisms and Innovative Clinical Treatments for Melanoma

Epigenetic Modification of PD-1/PD-L1-Mediated Cancer Immunotherapy against Melanoma

Progress of targeted therapy and immunotherapy for advanced melanoma

Targeted therapeutic strategies for melanoma